SPML

Speciality Medicines Limited, incorporated in 2021, operates in the pharmaceutical industry with a focus on the marketing and distribution of finished formulations of speciality pharmaceuticals. The company is involved in the development and commercialization of specialty pharmaceutical products, emphasizing clinical development to provide treatment options supported by scientific data. It builds dedicated front-end infrastructure to ensure efficient product availability and facilitates direct engagement with healthcare professionals. The company's operations target regulated and global markets. There are no publicly listed subsidiaries or ventures associated with Speciality Medicines Limited, and no information about founders or key management has been provided.